DelveInsight's "FILSPARI Market Size, Forecast, and Market Insight Report" highlights the details around FILSPARI, the first ...

Creatine supplements demonstrated a hint of promise for people with Alzheimer's disease in the pilot CABA trial. In the ...

FILSPARI holds strong market potential as the first FDA-approved non-immunosuppressive therapy for IgA nephropathy, a rare kidney disease with significant unmet needs. As more patients and providers ...

Creatine is a naturally occurring substance that provides energy. Your body—specifically your liver, kidneys, and ...

Discover which everyday foods trigger harmful inflammation and increase disease risk. Learn anti-inflammatory alternatives to ...

The market for hypercalcemia treatment is expected to reach approximately USD 22,640.2 million in 2025 and expand to around USD 52,303.9 million by 2035, reflecting a compound annual growth rate (CAGR ...

Learn the dangerous waist warning signs that predict serious health problems. Discover what happens when you ignore these ...

WHEN Leigh-Ann Turpin finished a marathon she should have been celebrating. Instead, she was humiliated by her photo at the finishing line. Weighing 20 stone, the 42-year-old was shocked she had ...

A recent study reveals that blood type incompatibility is a significant barrier for kidney transplants in India, with 87% of ...

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...

Scientists have identified microRNA able to protect small blood vessels and support kidney function after severe injury.